Dexmedetomidine
| Dexmedetomidine | |
|---|---|
| Salts [] | |
|---|---|
| Dexmedetomidine hydrochloride | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 200.28 g/mol [1] |
| Solubility | Freely soluble in water [1] |
| Predicted LogP | 3.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H16N2 [1] |
| IUPAC name | 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole [1] |
| SMILES | CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C [1] |
| InChI | InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1 [1] |
| InChIKey | CUHVIMMYOGQXCV-NSHDSACASA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 2 – 4 hours |
Dexmedetomidine (also known as Dexmedetomidine, Dexmedetomidina, Dexmedetomidinum, MPV 1440, MPV-1440, Medetomidine, (s)-, 4-((S)-α,2,3-Trimethylbenzyl)imidazole, 4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, CHEBI:4466 or Dtxsid10873388) is a
Chemistry
Salts []
Dexmedetomidine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Dexmedetomidine is a absolute mixture.
Pharmacology
ATC Classification
In the nervous system (N) dexmedetomidine acts as a dexmedetomidine (N05CM18), hypnotics and sedative (N05C), other hypnotics and sedative (N05CM) and psycholeptic (N05).[1]Metabolism
Interactions
| CYP2A6 | inhibition |
|---|---|
| CYP2C19 | induction / inhibition |
| CYP2D6 | induction / inhibition |
Subjective effects []
| bonzi / Dexmedetomidine [] | |
|---|---|
Legal status []
- Australia: Dexmedetomidine is a S4 substance.[3]
- Brazil: Dexmedetomidine is a C1 substance.
- United States: Dexmedetomidine is a prescription only substance.
- European Union: Dexmedetomidine is a prescription only substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5311068, Dexmedetomidine. Accessed April 16, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5311068
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dexmedetomidine. UNII: 67VB76HONO. Global Substance Registration System. Accessed April 16, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/67VB76HONO
DEXMEDETOMIDINE FRESENIUS (Fresenius Kabi Australia Pty Ltd). Accessed April 16, 2026. https://www.tga.gov.au/resources/prescription-medicines-registrations/dexmedetomidine-fresenius-fresenius-kabi-australia-pty-ltd